22 September 2006
BDI - BioDiesel International AG, Parkring 18, 8074 Grambach, Austria, together with Sal. Oppenheim jr. & Cie. KGaA today have set the purchase price for up to 1,250,000 offered shares of BDI - BioDiesel International AG and for up to 187,500 shares to cover over-allotments at EUR 58. The price is therewith in the upper half of the EUR 53 to EUR 62 price range. The total placement volume, including the over-allotment, amounts to 1,437,500 shares. 800,000 shares thereof resulted from a capital increase.
The net proceeds for the company will amount to approximately EUR 43 million (after IPO costs). The issue was more than two times oversubscribed.
Over 15 per cent of the shares offered were placed with private investors. Private investors that have not subscribed with one of the syndicate banks have not been allowed for subscription. The allotment for retail investors follow standardised criteria for all syndicate banks. Up to 20 shares, orders were fully allocated and, to the extent orders exceeded 20 shares, 55 per cent of the subscribed shares were allocated.
Additional Information: ISIN: AT0000A02177 Exchange Symbol: D7I Listing: Regulated Market (Prime Standard) of the Frankfurt Stock Exchange Registered office of the company: Austria
For further information please refer to the website www.BDI-BioDiesel.com.
Kirchhoff Consult AG Dr. Kay Baden Geschäftsleitung Tel. (040) 60 91 86 39
This publication is issued for advertising purposes. It is neither an offer to sell nor an invitation to buy securities. The offer will be made exclusively through and on the basis of a securities prospectus to be published in the course of a potential initial public offering that subject to approval can be obtained free of charge from the company, the syndicate banks and the stock exchange admission authorities.
This document is neither an offer to sell nor an invitation to submit an offer to buy securities in the United States of America. The shares in BDI - BioDiesel International AG (the "shares") may not be offered or sold in the United States or to "U.S persons" (as defined in Regulation S of the U.S. Securities Act of 1933 in the version (of the "Securities Act") in force at the time in question) or for the account of U.S. persons, unless they are registered or exempted from the requirement to register in accordance with the Securities Act. The shares are not and will not be registered in accordance with the Securities Act.
--- End of Ad-hoc Message --- WKN: A0LAXT; ISIN: AT0000A02177; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse;